Replies to post #15296 on Medicine Man Technologies Inc (SHWZ)

[Drugdoctor]

It’s clear at this point that Q4 cannabis sales will be worse than Q3, but with croptober a normal event, no one should be surprised. Markets are forward looking so Q1 and full year 2022 guidance is what investors should focus on when we hit earnings season in Mar.

— MJ Stock Trader (@stock_mj) January 22, 2022